Panel Discussion: Navigating the Clinical Challenges as Complement Inhibitors are Applied to Larger Patient Populations
Time: 10:30 am
day: Conference Day One
Details:
- Discussing the critical considerations for managing systemic complement inhibition and minimizing off-target effects and infection risks in a diverse patient cohort
- Overcoming diagnostic and biomarker limitations to accurately identify which patients within larger populations will truly benefit from complement inhibition
- Exploring innovative drug delivery modalities are essential to improve patient convenience and adherence for chronic use in larger populations
